Palpable breast masses are common among biological females, including pregnant and lactating individuals. Although most palpable breast masses are benign, breast cancer is one of the most common cancers. In 2019, there were an estimated 3.7 million individuals living with female breast cancer in the United States.1 Therefore, it is important that clinicians have the knowledge to appropriately evaluate breast masses. Risk factors for female breast cancer include, but are not limited to, exposure to menopausal hormone therapy, personal or family history of breast cancer, gene variants, chest wall radiation, age of menarche younger than 12 years, obesity, and alcohol use.2 A systematic approach for breast mass evaluation can help clinicians identify clinical features that increase suspicion of malignancy. Physical examination, breast imaging, and tissue biopsy are key diagnostic tools. For individuals who are younger than 30 years, lactating, or pregnant, the initial evaluation includes ultrasound, whereas mammogram with ultrasound is recommended for individuals 30 years or older.3,4 Tissue biopsy is necessary to evaluate a clinically suspicious mass.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Monique Swain, MD, Obstetrics and Gynecology Department, Henry Ford Hospital/Michigan State University School of Medicine, 3031 W Grand Blvd, New Center One Building, Seventh Floor, Detroit, MI 48202 (firstname.lastname@example.org).
Published Online: June 30, 2022. doi:10.1001/jama.2022.9554
Conflict of Interest Disclosures: None reported.
Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
You currently have no searches saved.
You currently have no courses saved.